Loading patent…
AssigneeIronwood Pharmaceuticals, Inc.
InventorMark G. Currie
Estimating the term…
Disclosed herein are novel compositions and methods for treating or preventing metabolic syndromes. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a combination of at least one antidiabetic agent, at least one proton pump inhibitor and at least one bile acid sequestrant, and, optionally, at least one active agent, including, but not limited to, dyslipidemia agents, histamine H2 receptor blockers, antacids, γ-aminobutyricacid-b (GABA-B) agonists, prodrugs of GABA-B agonists, protease inhibitors and combinations of two or more thereof.
A composition comprising a therapeutically effective amount of at least one antidiabetic agent, at least one proton pump inhibitor and at least one bile acid sequestrant.
4-9. (canceled)
(canceled)
17-19. (canceled)
21-22. (canceled)
A method for treating a disorder selected from metabolic syndrome, type 2 diabetes, or a condition associated with type 2 diabetes or metabolic syndrome, the method comprising administering to a patient having or at risk of developing said disorder or condition a therapeutically effective amount of at least one proton pump inhibitor and at least one bile acid sequestrant.
26-34. (canceled)
37-38. (canceled)
(canceled)
A method for treating GERD in a diabetic patient, the method comprising administering to the diabetic patient having or at risk of developing GERD a therapeutically effective amount of at least one antidiabetic agent, at least one proton pump inhibitor and at least one bile acid sequestrant.
(canceled)
Dependencies are inferred from the claim text.